These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2949588)

  • 1. Hemodynamic effects of PN 200-110 (isradipine) in congestive heart failure.
    Greenberg B; Siemienczuk D; Broudy D
    Am J Cardiol; 1987 Jan; 59(3):70B-74B. PubMed ID: 2949588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of the calcium antagonist PN 200-110 in patients with congestive heart failure.
    Broudy DR; Greenberg BH; Siemienczuk D
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):190-5. PubMed ID: 2441170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic study of short- and long-term isradipine treatment in patients with chronic ischemic congestive heart failure.
    McGrath BP; Newman R; Older P
    Am J Med; 1989 Apr; 86(4A):75-80. PubMed ID: 2523660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic and long-term clinical effects of isradipine in patients with coronary artery disease and chronic heart failure. A double-blind, placebo-controlled study.
    van den Toren EW; van Veldhuisen DJ; van Bruggen A; van den Broek SA; van Gilst WH; Lie KI
    Int J Cardiol; 1996 Jan; 53(1):37-43. PubMed ID: 8776276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
    Hansson L; Dahlof B
    Am J Cardiol; 1987 Jan; 59(3):137B-140B. PubMed ID: 2949584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure.
    Ferlinz J; Citron PD
    Am J Cardiol; 1983 May; 51(8):1339-45. PubMed ID: 6846161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of essential hypertension with PN 200-110 (isradipine).
    Hamilton BP
    Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Sievert A; Aurell M; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S102-4. PubMed ID: 2455104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F
    Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic effects of intravenous isradipine.
    van den Berg EK; Dehmer GJ
    Am J Cardiol; 1988 May; 61(13):1102-5. PubMed ID: 2966552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
    Elkayam U; Weber L; McKay CR; Rahimtoola SH
    Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Static exercise with congestive heart failure and the response to vasodilating drugs.
    Broudy DR; Greenberg BH; Siemienczuk D; Reinhart S; Morris C; Demots H
    Am J Cardiol; 1987 Jan; 59(1):100-4. PubMed ID: 3812218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
    Mauser M; Voelker W; Karsch KR
    Z Kardiol; 1988 Jun; 77(6):373-7. PubMed ID: 2975095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
    Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of dibutyryl cyclic AMP in congestive heart failure.
    Matsui S; Murakami E; Takekoshi N; Emoto J; Matoba M
    Am J Cardiol; 1983 May; 51(8):1364-8. PubMed ID: 6303101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability and efficacy of PN 200-110, a new calcium antagonist in patients with angina and coronary heart disease.
    Handler CE; Sowton E
    Eur J Clin Pharmacol; 1984; 27(4):415-7. PubMed ID: 6240405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations.
    Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko MK; Wiesner RH; Krom RA
    Am J Hypertens; 2000 Mar; 13(3):231-9. PubMed ID: 10777026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.
    Elkayam U; Weber L; McKay C; Rahimtoola S
    Am J Cardiol; 1985 Sep; 56(8):560-6. PubMed ID: 4036843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris.
    Taylor SH; Jackson NC; Allen J; Pool PE
    Am J Cardiol; 1987 Jan; 59(3):123B-129B. PubMed ID: 2949583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
    Cantelli I; Lolli C; Brunelli A; Bracchetti D
    Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.